Human Antihemophilic Factors
- Name
- Human Antihemophilic Factors
- Accession Number
- DBCAT003250
- Description
Not Available
- Drugs
Drug Drug Description Antihemophilic factor, human recombinant A form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency. Antihemophilic factor human A Factor VIII replacement therapy used to treat hemophilia A. Beroctocog alfa Beroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in... Antihemophilic factor (recombinant), PEGylated For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... Efmoroctocog alfa A recombinant Factor VIII used to treat and prevent bleeding in hemophilia A. - Drugs & Drug Targets